Charisse Prall
Family · Elkhart, INNPI 1699292722
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.4% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,528, more than ten times the $46 reported in 2021.
Across 132 payments — averaging $21.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$343
- Novartis$206
- E.r. Squibb & Sons, L.L.C.$188
- Astellas Pharma US Inc$171
- Eisai Inc.$158
- Pfizer$154
- plus $2K from 34 others
What the payments were for
- Food & beverage$2,64993%
- Education$1887%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 16 | $343 |
| Novartis | 12 | $206 |
| E.r. Squibb & Sons, L.L.C. | 8 | $188 |
| Astellas Pharma US Inc | 4 | $171 |
| Eisai Inc. | 9 | $158 |
| Pfizer | 9 | $154 |
| Merck | 7 | $152 |
| AbbVie | 6 | $130 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $120 |
| Jazz Pharmaceuticals Inc. | 4 | $102 |
| GSK | 4 | $97 |
| Incyte Corporation | 3 | $70 |
| Exelixis Inc. | 3 | $67 |
| GE HealthCare | 3 | $61 |
| Genentech USA, Inc. | 3 | $59 |
| AstraZeneca | 3 | $55 |
| Boehringer Ingelheim | 2 | $53 |
| Geron Corporation | 2 | $52 |
| Bristol Myers Squibb | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Sobi, Inc | 2 | $34 |
| Bayer | 2 | $34 |
| Argenx US, Inc. | 1 | $31 |
| Legend Biotech USA Inc. | 2 | $30 |
| Tempus AI, Inc | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Sanofi | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Pharmaessentia USA Corporation | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Curium US LLC | 1 | $22 |
| Puma Biotechnology, Inc. | 1 | $21 |
| Aadi Bioscience, Inc. | 1 | $19 |
| AVEO Pharmaceuticals, Inc. | 1 | $19 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
How this compares
$2,836 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.
Other family in Elkhart
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.